Rakovina Therapeutics: AI a "paradigm shift" for cancer drug development
Rakovina Therapeutics Inc (TSX-V:RKV), a Canadian biotechnology company focused on developing innovative therapies for the treatment of cancer, experienced...
Source: proactiveinvestors.com